CDH17 and neoplasm: Mechanistically, these observations align with bioinformatic analyses highlighting PDGFRβ as an upstream regulator of multiple downstream effectors—PPARγ, VEGFA, ANG-2, VIM, COL1A1, and Cadherins all integral to tumor progression, angiogenesis, and cellular plasticity.